Bell R
NHS Centre for Reviews and Dissemination, University of York.
Nurs Times. 1999;95(3):52-3.
New screening methods need to be fully evaluated to assess whether they should be introduced in the NHS. This article summarises a systematic review of research on screening for ovarian cancer. There is no evidence that screening reduces the death rate and there is the potential for significant harm from diagnostic surgery in women with false positive results. Screening should be done only within well-conducted research trials.
新的筛查方法需要进行全面评估，以确定是否应在英国国家医疗服务体系（NHS）中采用。本文总结了一项关于卵巢癌筛查研究的系统评价。没有证据表明筛查能降低死亡率，而且假阳性结果的女性接受诊断性手术存在重大伤害的可能性。筛查应仅在精心开展的研究试验中进行。
